期刊文献+

Inhibition of γ-synuclein (SNCG) expression in breast cancer MDA-MB231 cell line

抑制SNCG阳性表达乳腺癌细胞株MDA-MB231的实验研究(英文)
在线阅读 下载PDF
导出
摘要 Objective:The aim of the study was to evaluate the inhibition of different chemotherapy drugs on γ-synuclein (SNCG) positive expression of breast cancer cell line MDA-MB231,and the effects on cell cycle and apoptosis,and to explore the related mechanism as well.Methods:We treated the breast cancer cell line MDA-MB231 for the inhibition of SNCG with chemotherapy drugs such as irinotecan,nedaplatin and 5-fluorouracil using RT-PCR and immunohistochemistry,and adopted flow cytometry to detect cell cycle distribution and apoptosis.Results:At the transcription and translation levels,the SNCG expression level in nedaplatin group and 5-fluorouracil group was lower than that of other groups and there was statistically significance (P < 0.01) compared with the control group,while there was not statistically significant between irinotecan group and the control group.After drugs action,cell cycle and distribution in each experiment group changed obviously,where the cells in G0G1 phase increased,especially the cells in the nedaplatin group and 5-fluorouracil group changed most significantly,as well as the obvious change in the cells of nedaplatin group and 5-fluorouracil group in the apoptosis period.Conclusion:There was a stronger inhibition of SNCG expression in nedaplatin and 5-fluorouracil groups,and can cause significant cell cycle and apoptosis changes.It may also be concluded that nedaplatin and 5-fluorouracil could make effects by the mechanisms of inhibiting cancer cell proliferation and inducing cell apoptosis.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2012年第3期156-159,共4页 中德临床肿瘤学杂志(英文版)
基金 Supported by the grant of Youth Fund Projects of Sichuan Provincial Department of Education (No. 11ZB163)
关键词 γ-synuclein (SNCG) MDA-MB231 cells breast cancer RT-PCR 有限责任公司 细胞株 乳腺癌 抑制作用 细胞凋亡 氟尿嘧啶 细胞周期 RT-PCR
  • 相关文献

参考文献4

二级参考文献27

  • 1王玉栋,刘巍,张志刚,张祥宏,王俊灵,严霞.新辅助化疗对乳腺癌组织BCSG1和maspin表达的影响[J].中华肿瘤防治杂志,2006,13(9):680-684. 被引量:1
  • 2Ji HJ, Liu YE ,Jia TL, et al. Identification of a breast cancer-specific gene,BCSG1,by direct differential cDNA sequencing. Cancer Res, 1997,57:759-764.
  • 3Ninkina NN, Alimova-Kost MV, Paterson JW, et al. Organization, expression and polymorphism of the human persyn gene. Human Molecular Genetics,1998,7:1417-1424.
  • 4Bruening W, Giasson BI, Klein-Szanto AJ, et al. Synuclleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer,2000,88:2154-2163.
  • 5Fuqua SA. The role of estrogen receptors in breast cancer metastasis. J Mammary Gland Biol Neoplasia, 2001,6:404-417.
  • 6Osborne CK, Schiff R, Fuqua SA, et al. Estrogen receptor: current understanding of its activation and modulation. Clin Cancer Res, 2001,7 Suppl 12: 4338s-4342s.
  • 7Horita K, Yamaguchi A, Hirose K, et al. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer. Eur J Histochem, 2001,45: 73-84.
  • 8Menard S, Fortis S, Castiglioni F, et al. HER2 as a prognostic factor in breast cancer. Oncology, 2001,61 Suppl 2: 67-72.
  • 9Jia TL, Liu YE, Liu JW, et al. Stimulation of breast cancer invasion and metastasis by synuclein γ1. Cancer Res, 1999,59:742-747.
  • 10Liu J, Spence MJ, Zhang YL, et al. Transcriptional suppression of synuclein-7(SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M [ J ]. Breast Cancer Res Treat, 2000, 62 (2) : 99 - 107.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部